Pharma Reviews: DNA Money Edit: Indian pharma faces pricing troubles in US

It isn't a great time for the pharma sector. While the March quarter has been a mixed bag in terms of earnings for Indian pharma companies, the recent ...
Read more: DNA Money Edit: Indian pharma faces pricing troubles in US